Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Peringkat dalam Saham #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Harga Saham
$0.00023723
Terakhir disinkronkan: 2024-08-26
Kapitalisasi Pasar
$1.41K
Perubahan (1 hari)
111.67%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Pharnext S.A. (ALPHA)

Kategori

Riwayat dividen untuk Pharnext S.A. (ALPHA)
Saham Pharnext S.A. (simbol: ALPHA) telah membayar total 1 dividen.
Total semua dividen (disesuaikan dengan stock split): $0.20
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Pharnext S.A. (ALPHA) dari 2024 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR